Bladder Control Treatment and Symptoms trials Urinary Incontinence
Urinary incontinence is the involuntary excretion of urine from one's body. It is often temporary, and it almost always results from an underlying medical condition. In this article, the term "incontinence" will be used to mean urinary incontinence. See also fecal incontinence. Types of incontinence Stress incontinence Stress incontinence is incontinence caused by coughing, laughing, sneezing, exercising or other movements that increase intrabdominal pressure and thus increase pressu ...
Wikipedia - [full article]
Bladder Control Clinical Trials
- Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder
ClinicalTrials.gov Identifier: NCT00084578 - Completed
stage 0 bladder cancer; stage I bladder cancer; stage II bladder cancer; stage III bladder cancer; stage IV bladder cancer; ...
- Genistein in Treating Patients Who Are Undergoing Surgery for Bladder Cancer
ClinicalTrials.gov Identifier: NCT00118040 - Suspended
stage 0 bladder cancer; recurrent bladder cancer; stage I bladder cancer; stage II bladder cancer; stage III bladder cancer; stage IV bladder cancer
- Gene Therapy in Treating Patients With Advanced Bladder Cancer
ClinicalTrials.gov Identifier: NCT00003167 - Completed
stage III bladder cancer; stage II bladder cancer; transitional cell carcinoma of the bladder; stage I bladder cancer; recurrent bladder cancer; ...
- Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer
ClinicalTrials.gov Identifier: NCT00042887 - Active, not recruiting
stage 0 bladder cancer; stage I bladder cancer; recurrent bladder cancer; transitional cell carcinoma of the bladder
- Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
ClinicalTrials.gov Identifier: NCT00024349 - Recruiting
stage II bladder cancer; stage III bladder cancer; transitional cell carcinoma of the bladder; squamous cell carcinoma of the bladder; ...
- Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer
ClinicalTrials.gov Identifier: NCT00089128 - Active, not recruiting
transitional cell carcinoma of the bladder; recurrent bladder cancer; stage III bladder cancer; stage IV bladder cancer
- High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer
ClinicalTrials.gov Identifier: NCT00003623 - Active, not recruiting
transitional cell carcinoma of the bladder; stage I bladder cancer; stage 0 bladder cancer; prevention of bladder cancer
- Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer
ClinicalTrials.gov Identifier: NCT00033436 - Active, not recruiting
stage I bladder cancer; stage II bladder cancer; stage III bladder cancer; transitional cell carcinoma of the bladder
- Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
ClinicalTrials.gov Identifier: NCT00003725 - Active, not recruiting
transitional cell carcinoma of the bladder; stage I bladder cancer; stage 0 bladder cancer; recurrent bladder cancer
- Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer
ClinicalTrials.gov Identifier: NCT00054626 - Recruiting
stage II bladder cancer; stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder
- Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer
ClinicalTrials.gov Identifier: NCT00095589 - Recruiting
Bladder Cancer; stage 0 bladder cancer; stage I bladder cancer; transitional cell carcinoma of the bladder
- Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin
ClinicalTrials.gov Identifier: NCT00234039 - Recruiting
Recurrent Bladder Cancer; Stage 0 Bladder Cancer; Stage I Bladder Cancer; Transitional Cell Carcinoma of the Bladder
- Eflornithine in Treating Patients With Bladder Cancer
ClinicalTrials.gov Identifier: NCT00003814 - Completed
transitional cell carcinoma of the bladder; stage I bladder cancer; stage 0 bladder cancer; recurrent bladder cancer
- Tipifarnib in Treating Patients With Recurrent Bladder Cancer
ClinicalTrials.gov Identifier: NCT00047216 - Completed
recurrent bladder cancer; stage 0 bladder cancer; stage I bladder cancer; transitional cell carcinoma of the bladder
- R115777 in Treating Patients With Advanced Bladder Cancer
ClinicalTrials.gov Identifier: NCT00006376 - Active, not recruiting
stage III bladder cancer; stage II bladder cancer; regional transitional cell cancer of the renal pelvis and ureter; ...
- BCG With or Without Mitomycin in Treating Patients With Bladder Cancer
ClinicalTrials.gov Identifier: NCT00023842 - Active, not recruiting
stage 0 bladder cancer; recurrent bladder cancer; transitional cell carcinoma of the bladder
- Chemotherapy in Treating Patients With Early-Stage Bladder Cancer
ClinicalTrials.gov Identifier: NCT00003129 - Active, not recruiting
transitional cell carcinoma of the bladder; stage I bladder cancer; stage 0 bladder cancer
- Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer
ClinicalTrials.gov Identifier: NCT00003824 - Active, not recruiting
transitional cell carcinoma of the bladder; stage 0 bladder cancer; recurrent bladder cancer
- Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder Cancer
ClinicalTrials.gov Identifier: NCT00006118 - Active, not recruiting
stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder
- Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer
ClinicalTrials.gov Identifier: NCT00003342 - Active, not recruiting
stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder; ...
- Combination Chemotherapy in Treating Patients With Bladder Cancer
ClinicalTrials.gov Identifier: NCT00005047 - Active, not recruiting
stage I bladder cancer; stage II bladder cancer; transitional cell carcinoma of the bladder
- Combination Chemotherapy in Treating Patients With Bladder Cancer
ClinicalTrials.gov Identifier: NCT00014534 - Active, not recruiting
stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder
- Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer
ClinicalTrials.gov Identifier: NCT00052637 - Active, not recruiting
Bladder Cancer; recurrent bladder cancer; stage 0 bladder cancer
- Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer
ClinicalTrials.gov Identifier: NCT00004223 - Active, not recruiting
stage III bladder cancer; regional transitional cell cancer of the renal pelvis and ureter; transitional cell carcinoma of the bladder; ...
- Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer
ClinicalTrials.gov Identifier: NCT00088946 - Active, not recruiting
transitional cell carcinoma of the bladder; stage 0 bladder cancer; stage I bladder cancer
- Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer
ClinicalTrials.gov Identifier: NCT00006105 - Active, not recruiting
stage II bladder cancer; stage III bladder cancer; stage IV bladder cancer; Drug Toxicity
- Oxaliplatin in Treating Patients With Metastatic Bladder Cancer
ClinicalTrials.gov Identifier: NCT00004203 - Active, not recruiting
transitional cell carcinoma of the bladder; recurrent bladder cancer; stage IV bladder cancer; ...
- Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer
ClinicalTrials.gov Identifier: NCT00003642 - Active, not recruiting
stage III bladder cancer; stage II bladder cancer; transitional cell carcinoma of the bladder
- SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract
ClinicalTrials.gov Identifier: NCT00006351 - Active, not recruiting
recurrent bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder; recurrent urethral cancer; anterior urethral cancer; ...
- Surgery and BCG in Treating Patients With Bladder Cancer
ClinicalTrials.gov Identifier: NCT00002990 - Active, not recruiting
stage 0 bladder cancer; stage I bladder cancer; transitional cell carcinoma of the bladder
- Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
ClinicalTrials.gov Identifier: NCT00003640 - Active, not recruiting
stage III bladder cancer; stage II bladder cancer; childhood kidney/urinary cancer; transitional cell carcinoma of the bladder
- Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium
ClinicalTrials.gov Identifier: NCT00003376 - Active, not recruiting
stage III bladder cancer; stage IV bladder cancer; urethral cancer associated with invasive bladder cancer; ...
- ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract
ClinicalTrials.gov Identifier: NCT00014144 - Active, not recruiting
recurrent urethral cancer; transitional cell carcinoma of the bladder; recurrent bladder cancer; stage IV bladder cancer; ...
- Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium
ClinicalTrials.gov Identifier: NCT00028756 - Recruiting
stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder
- AD 32 Alone or With BCG Following Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer
ClinicalTrials.gov Identifier: NCT00003759 - Completed
stage I bladder cancer; stage 0 bladder cancer; recurrent bladder cancer
- BCG Plus Interferon alfa 2b in Treating Patients With Bladder Cancer
ClinicalTrials.gov Identifier: NCT00004122 - Completed
transitional cell carcinoma of the bladder; stage I bladder cancer; recurrent bladder cancer; Quality of Life
- Fenretinide to Prevent Cancer Recurrence in Treating Patients With Bladder Cancer
ClinicalTrials.gov Identifier: NCT00004154 - Completed
stage 0 bladder cancer; stage I bladder cancer; transitional cell carcinoma of the bladder
- Gemcitabine in Treating Patients With Recurrent or Refractory Bladder Cancer
ClinicalTrials.gov Identifier: NCT00014287 - Completed
stage I bladder cancer; stage 0 bladder cancer; recurrent bladder cancer
- Paclitaxel in Treating Patients With Early-Stage Bladder Cancer
ClinicalTrials.gov Identifier: NCT00002917 - Completed
transitional cell carcinoma of the bladder; stage I bladder cancer; stage 0 bladder cancer
- Suramin in Treating Patients With Recurrent Bladder Cancer
ClinicalTrials.gov Identifier: NCT00006476 - Completed
stage 0 bladder cancer; stage I bladder cancer; recurrent bladder cancer
- Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
ClinicalTrials.gov Identifier: NCT00022191 - Active, not recruiting
stage IV bladder cancer; transitional cell carcinoma of the bladder; urethral cancer associated with invasive bladder cancer; ...
- Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer
ClinicalTrials.gov Identifier: NCT00003133 - Active, not recruiting
stage III bladder cancer; stage IV bladder cancer; metastatic transitional cell cancer of the renal pelvis and ureter; ...
- Combination Chemotherapy in Treating Patients With Bladder Cancer
ClinicalTrials.gov Identifier: NCT00003701 - Active, not recruiting
stage III bladder cancer; childhood kidney/urinary cancer; transitional cell carcinoma of the bladder; ...
- Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer
ClinicalTrials.gov Identifier: NCT00005958 - Active, not recruiting
stage III bladder cancer; regional transitional cell cancer of the renal pelvis and ureter; transitional cell carcinoma of the bladder; ...
- Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract
ClinicalTrials.gov Identifier: NCT00002914 - Active, not recruiting
recurrent urethral cancer; transitional cell carcinoma of the bladder; recurrent bladder cancer; ...
- Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract
ClinicalTrials.gov Identifier: NCT00006111 - Active, not recruiting
stage III bladder cancer; stage II bladder cancer; regional transitional cell cancer of the renal pelvis and ureter; anterior urethral cancer; ...
- Pemetrexed Disodium in Treating Patients With Locally Advanced or Metastatic Recurrent Cancer of the Urothelium
ClinicalTrials.gov Identifier: NCT00039260 - No longer recruiting
recurrent bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder; ...
- Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
ClinicalTrials.gov Identifier: NCT00066352 - Completed
recurrent bladder cancer; stage IV bladder cancer; metastatic transitional cell cancer of the renal pelvis and ureter; ...
- Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer
ClinicalTrials.gov Identifier: NCT00028860 - Completed
stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder; ...
- Arsenic Trioxide in Treating Patients With Recurrent Bladder or Urinary Tract Cancer
ClinicalTrials.gov Identifier: NCT00009867 - Active, not recruiting
recurrent urethral cancer; transitional cell carcinoma of the bladder; recurrent bladder cancer; ...
- Biological Therapy in Treating Patients With Bladder Cancer
ClinicalTrials.gov Identifier: NCT00003779 - Active, not recruiting
stage I bladder cancer; stage 0 bladder cancer
- Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer
ClinicalTrials.gov Identifier: NCT00002919 - Active, not recruiting
stage II bladder cancer; transitional cell carcinoma of the bladder
- Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer
ClinicalTrials.gov Identifier: NCT00005086 - Active, not recruiting
transitional cell carcinoma of the bladder; stage IV bladder cancer
- Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
ClinicalTrials.gov Identifier: NCT00003930 - Active, not recruiting
stage III bladder cancer; stage II bladder cancer
- Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer
ClinicalTrials.gov Identifier: NCT00002490 - Active, not recruiting
stage I bladder cancer; transitional cell carcinoma of the bladder
- Vaccine Therapy in Treating Patients With Transitional Cell Cancer of the Bladder
ClinicalTrials.gov Identifier: NCT00070070 - Active, not recruiting
transitional cell carcinoma of the bladder; stage I bladder cancer
- Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis
ClinicalTrials.gov Identifier: NCT00002949 - Active, not recruiting
stage III bladder cancer; stage III endometrial cancer; stage II bladder cancer; stage II cervical cancer; stage III cervical cancer; ...
- Combination Chemotherapy and Radiation Therapy With or Without Surgery In Treating Patients With Stage II or Stage III Bladder Cancer
ClinicalTrials.gov Identifier: NCT00055601 - Recruiting
stage II bladder cancer; stage III bladder cancer
- Antineoplaston Therapy in Treating Patients With Stage IV Bladder Cancer
ClinicalTrials.gov Identifier: NCT00003452 - Recruiting
Recurrent Bladder Cancer; Stage IV Bladder Cancer
- Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment
ClinicalTrials.gov Identifier: NCT00016237 - Completed
extensive stage small cell lung cancer; stage IV non-small cell lung cancer; Stage IV Renal Cell Cancer; Squamous Cell Lung Cancer; ...
- Keyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder Cancer
ClinicalTrials.gov Identifier: NCT00006034 - Suspended
stage 0 bladder cancer; recurrent bladder cancer
- Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ
ClinicalTrials.gov Identifier: NCT00462488 - Recruiting
Urinary Bladder Cancer; Bladder Cancer; Bladder Neoplasms; Bladder Tumors
- Prospective Trial to Evaluate Efficacy and Accuracy of a Portable Ultrasound Scanner for Non-Invasive Bladder Volume Measurement (BladderScan BVI3000) in Patients After Radical Cystectomy and Bladder Reconstruction
ClinicalTrials.gov Identifier: NCT00512174 - Recruiting
Bladder Substitution; Reconstructed Bladder
- Electrical Control of Bladder in Spinal Cord Injury Patients
ClinicalTrials.gov Identifier: NCT00011570 - Active, not recruiting
Spinal Cord Injury
- Celecoxib in Treating Patients With Bladder Cancer
ClinicalTrials.gov Identifier: NCT00006124 - Active, not recruiting
recurrent bladder cancer
- Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer
ClinicalTrials.gov Identifier: NCT00003105 - Active, not recruiting
Bladder Cancer; transitional cell cancer of the renal pelvis and ureter
- Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer
ClinicalTrials.gov Identifier: NCT00003175 - Active, not recruiting
recurrent transitional cell cancer of the renal pelvis and ureter; recurrent urethral cancer; childhood kidney/urinary cancer; ...
- Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer
ClinicalTrials.gov Identifier: NCT00041106 - Active, not recruiting
Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
- Cost-Effectiveness in Bladder Cancer
ClinicalTrials.gov Identifier: NCT00126958 - Active, not recruiting
Bladder Cancer
- Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients with Advanced Transitional Cell Cancer of the Bladder
ClinicalTrials.gov Identifier: NCT00136175 - Active, not recruiting
Bladder Cancer
- Phase II Trial of EOquin in High-Risk Superficial Bladder Cancer
ClinicalTrials.gov Identifier: NCT00141531 - Active, not recruiting
Bladder Neoplasms
- A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR)
ClinicalTrials.gov Identifier: NCT00337558 - Active, not recruiting
Overactive Bladder; Urinary Incontinence; Urge Incontinence
- Analysis of Expression of Nitric Oxide Syntheses and Their Functional Role in Human Urothelium
ClinicalTrials.gov Identifier: NCT00253006 - Terminated
Painful Bladder Syndrome; Interstitial Cystitis; Bladder Disease; Incontinence
- Bladder Cancer Case Control Study of Arsenic in Water
ClinicalTrials.gov Identifier: NCT00011518 - Completed
Bladder Cancer
- Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy
ClinicalTrials.gov Identifier: NCT00072137 - Recruiting
Bladder Cancer
- Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure
ClinicalTrials.gov Identifier: NCT00109655 - Recruiting
Carcinoma, Transitional Cell; Bladder Neoplasms
- Efficacy of Amitriptyline for Painful Bladder Syndrome(PBS)
ClinicalTrials.gov Identifier: NCT00124306 - Recruiting
painful bladder syndrome; Interstitial Cystitis
- Adjuvant Vs Progression-Triggered Gemcitabine-Monotherapy for Locally Advanced Bladder Cancer
ClinicalTrials.gov Identifier: NCT00146276 - Recruiting
Locally Advanced Bladder Cancer; Cystectomy
- Biobank Bladder Carcinoma
ClinicalTrials.gov Identifier: NCT00157365 - Recruiting
Bladder Cancer
- Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder (OAB). A Multicenter Phase II, Randomized, Double-Blind, Placebo Controlled 6 Month Study .
ClinicalTrials.gov Identifier: NCT00231491 - Recruiting
Overactive Bladder (OAB)
- Evaluation Study of Ultrasound Bladder Scanner for Monitoring Bladder Function
ClinicalTrials.gov Identifier: NCT00277615 - Recruiting
Dysfunction of the Urinary Bladder
- Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer
ClinicalTrials.gov Identifier: NCT00322699 - Recruiting
Superficial Bladder Cancer
- Study of Autologous Neo-Bladder Construct in Subjects With Neurogenic Bladder Following Spinal Cord Injury
ClinicalTrials.gov Identifier: NCT00512148 - Recruiting
Neurogenic Bladder
- Interdisciplinary Case-Control Study of Bladder Cancer in Spain
ClinicalTrials.gov Identifier: NCT00341861 - Active, not recruiting
Bladder Cancer
- LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00005858 - Completed
Lung Cancer; ovarian epithelial cancer; Pancreatic Cancer; ovarian sarcoma; Colon Cancer; Bladder Cancer; Breast Cancer
- Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium
ClinicalTrials.gov Identifier: NCT00080795 - Completed
stage III bladder cancer; regional transitional cell cancer of the renal pelvis and ureter; anterior urethral cancer; posterior urethral cancer; ...
- A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder
ClinicalTrials.gov Identifier: NCT00001381 - Completed
Bladder Neoplasms; Carcinoma, Transitional Cell
- A Phase 3, Parallel Group, Randomized, Double-Blind, Placebo Controlled Multicenter Trial to Investigate the Efficacy, Tolerability and Safety of Fesoterodine Sustained Release in Subjects with Overactive Bladder Syndrome
ClinicalTrials.gov Identifier: NCT00138723 - Completed
Overactive Bladder
- Evaluate Efficacy and Safety of Tolterodine Extended Release Capsule Compared with Tolterodine Immediate Release Tablet in Patients with Symptoms of Overactive Bladder
ClinicalTrials.gov Identifier: NCT00139724 - Completed
Overactive bladder
- Bortezomib in Treating Patients With Advanced Transitional Cell Carcinoma of the Urothelium
ClinicalTrials.gov Identifier: NCT00072150 - Active, not recruiting
Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
- Combination Chemotherapy Followed By Observation or Surgery in Treating Patients With Stage II or Stage III Cancer of the Urothelium
ClinicalTrials.gov Identifier: NCT00045630 - Active, not recruiting
Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
- Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer
ClinicalTrials.gov Identifier: NCT00002684 - Active, not recruiting
Bladder Cancer; Urethral Cancer
- Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function
ClinicalTrials.gov Identifier: NCT00005644 - Active, not recruiting
Bladder Cancer; Cancer of the Renal Pelvis and Ureter; Gastrointestinal Cancer; Urethral Cancer
- Decitabine in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00030615 - Active, not recruiting
adult solid tumor; Bladder Cancer; Breast Cancer; Male Breast Cancer; Melanoma
- FR901228 in Treating Patients With Advanced Cancer of the Urothelium
ClinicalTrials.gov Identifier: NCT00087295 - Active, not recruiting
Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
- Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract
ClinicalTrials.gov Identifier: NCT00022633 - Active, not recruiting
Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
- Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy
ClinicalTrials.gov Identifier: NCT00066612 - Active, not recruiting
Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
- Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
ClinicalTrials.gov Identifier: NCT00004095 - Active, not recruiting
Bladder Cancer; Breast Cancer; Colorectal Cancer; kidney tumor; Lung Cancer; Pancreatic Cancer
- Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract
ClinicalTrials.gov Identifier: NCT00006026 - Active, not recruiting
Bladder Cancer; Kidney Cancer; Urethral Cancer
- Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium
ClinicalTrials.gov Identifier: NCT00053209 - Active, not recruiting
Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
Resources
- About Incontinence (National Association for Continence)
- American Foundation for Urologic Disease